Bayer Diagnostics/Gen-Probe Primed For HCV Assay Panel Review, Arbitration
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe is entering arbitration with hepatitis C assay development partner Bayer Diagnostics while simultaneously preparing for FDA panel review of the quantitative test Dec. 13